Anthropic Opens a Biolab for Real-World Experiments

Anthropic has confirmed to TechCrunch that it operates a so-called "wet" biology lab in the San Francisco Bay Area, where its AI models can run real physical experiments. According to Eric Kauderer-Abrams, head of the company's life sciences work, the ultimate test in biology is still real lab work — and the company is already doing it. The lab is set up like an ordinary biotech facility: Anthropic conducts some of the research on its own, and some with outside partners.

The news isn't entirely out of the blue: back in April, Anthropic acquired Coefficient Bio, a stealth startup working at the intersection of AI and biotech. The company declined to share specifics about the lab's work, stressing only that the main focus is fundamental biology rather than drug development.

That caveat is no accident. Anthropic doesn't want to look like a competitor to the pharmaceutical industry, where it has plenty of major clients and partners: a joint drug-development effort with Novo Nordisk was recently announced. The company has already run into pushback when it released products perceived as rivaling its own customers' solutions. This week it launched a verification program for the life sciences, giving vetted researchers access to its most powerful models, and it published reports on accelerating protein design and on its work with biomolecular modeling.

Cure or Kill

Against this backdrop, the overall tone of the AI conversation stands out. A week earlier, Anthropic CEO Dario Amodei said AI could cure most serious diseases within 5–10 years — and to test hypotheses, a language model needs real experiments. At the same time, the industry is still reeling from the departure of Anthropic researcher Jacob Coxon, who warned that AI's creators seriously believe the technology could destroy humanity before the decade is out. The company's own head of alignment puts the odds of such an outcome over the next ten years at more than 10%.

Amodei himself, over the past weekend, called on the industry to slow down and adopt self-regulation, repeatedly naming bioterrorism as one of AI's biggest risks. The contrast between these grim forecasts and the opening of a biolab has not gone unnoticed in the industry. Investor and AI-startup founder Chamath Palihapitiya wrote wryly on X: "The team that brought you the hits 'We're all going to die' and 'Regulate me right now' is building a wet lab in San Francisco. Do not recommend."

Source: TechCrunch